About the Study

Hodgkin Lymphoma: A study to compare standard therapy to the use of two drugs, Brentuximab vedotin and Nivolumab

This study is being done for children and adults: • 5 to 60 years old. • Diagnosed with Hodgkin lymphoma (HL) The overall goal of this study is to compare the effects, good and/or bad, of brentuximab vedotin and nivolumab against standard therapy for people with HL to find out which is better.

Interested in learning more?

Full Study Name: AHOD2131 - A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma